Radioimmunoassay (RIA) is an in vitro assay which helps to measures the presence of an antigen with very high sensitivity. In radioimmunoassay radioactive versions of a substance, or isotopes of the substance, are mixed with antibodies and inserted in a sample of the patient's blood. The amount of free isotope is then calculated to see how much of the original substance was in the blood. RIA has many applications, such as narcotics drug detection, blood bank screening for the hepatitis virus, early cancer detection, diagnosis and treatment of peptic ulcers and in research with brain chemicals called neurotransmitters.
MARKET SCOPE
The "Global Radioimmunoassay Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Radioimmunoassay market with detailed market segmentation by, type, application, end user, and geography. The report provides key statistics on the market status of the leading Radioimmunoassay market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type, the global radioimmunoassay market is segmented reagents and kits, analyzers market
- based the basis of application, the market is segmented into research, clinical diagnostics.
- based the basis of end-user, the market is segmented into hospital, pharmaceutical industry and cro, academics, clinical diagnostic laboratories
MARKET DYNAMICS
Drivers:
- Rising use of radioimmunoassay techniques in cancer diagnosis and advancements in medical research
- In addition, it is also used in diagnosis of various other infectious diseases including neurodegenerative disorders
- Increasing RIA procedures in research centers
Restraints:
- The high cost
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Radioimmunoassay market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Radioimmunoassay market in these regions.
IMPACT OF COVID-19 ON RADIOIMMUNOASSAY MARKET
The fear of a lack of vital life-saving devices and other vital supplies to prevent the spread of the pandemic and provide optimal treatment for those infected grows as Covid-19 infects people all over the world. Furthermore, ventilators are an important option for treating COVID-19 patients who may require immediate attention until pharmaceutical therapy is developed.
MARKET PLAYERS
The report covers key developments in the Radioimmunoassay market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Radioimmunoassay market are anticipated to lucrative growth opportunities in the future with the rising demand for Radioimmunoassay in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Radioimmunoassay market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- DIAsource ImmunoAssays
- Beckman Coulter, Inc.
- IBL International (A Tecan Company)
- PerkinElmer, Inc.
- DRG International, Inc.
- MP Biomedicals, LLC
- Cisbio
- Euro Diagnostica AB
- DiaSorin S.p.A.
- EMD Millipore